Lannett Company Inc.: Drug Recall
Recall #D-0642-2025 · 08/19/2025
Class II: Risk
Recall Details
- Recall Number
- D-0642-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Lannett Company Inc.
- Status
- Ongoing
- Date Initiated
- 08/19/2025
- Location
- Seymour, IN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,848 bottles
Reason for Recall
Presence of Foreign Tablet/Capsule: Two (2) bottles labeled as Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100ct, contained one (1) tablet of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 5 mg.
Product Description
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets, 10mg, 100 Tablets per bottle, Rx only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 0527-0762-37.
Distribution Pattern
OH
Other Recalls by Lannett Company Inc.
- Class II: Risk 10/10/2025
- Class II: Risk 08/11/2025
- Class II: Risk 10/25/2024
- Class III: Low Risk 11/09/2022
- Class III: Low Risk 11/09/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.